Literature DB >> 16195799

Atypical teratoid/rhabdoid tumors of the central nervous system.

Alyssa T Reddy1.   

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant central nervous system neoplasm that usually affects very young children and is typically deadly despite very aggressive treatment. Considered rare, the tumor was not recognized as a distinct entity until the 80's, due to its similar features with other primitive tumors. Although AT/RT has become increasingly recognized, published data has been based on small series and are retrospective. Based on these data, there are occasional long-term survivors, most of whom received intensive multi-modal therapy. AT/RT is the first pediatric brain tumor for which a candidate tumor suppressor gene has been identified. A mutation or deletion in the INI1 gene occurs in the majority of AT/RT tumors. The function of the gene is not yet understood. Prospective clinical and biologic trials are greatly needed to understand the efficacy of therapeutic interventions, as well as the role of the gene.

Entities:  

Mesh:

Year:  2005        PMID: 16195799     DOI: 10.1007/s11060-005-6762-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.

Authors:  J A Biegel; B Fogelgren; L M Wainwright; J Y Zhou; H Bevan; L B Rorke
Journal:  Genes Chromosomes Cancer       Date:  2000-05       Impact factor: 5.006

2.  The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors.

Authors:  Jaclyn A Biegel; Ganjarn Kalpana; Erik S Knudsen; Roger J Packer; Charles W M Roberts; Carol J Thiele; Bernard Weissman; Malcolm Smith
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

3.  Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Authors:  Tanya M Tekautz; Christine E Fuller; Susan Blaney; Maryam Fouladi; Alberto Broniscer; Thomas E Merchant; Matthew Krasin; James Dalton; Gregory Hale; Larry E Kun; Dana Wallace; Richard J Gilbertson; Amar Gajjar
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

4.  Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.

Authors:  Jaclyn A Biegel; Lu Tan; Fan Zhang; Luanne Wainwright; Pierre Russo; Lucy B Rorke
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Malignant rhabdoid tumor of brain: an aggressive clinical entity.

Authors:  B J Fisher; J Siddiqui; D Macdonald; A E Cairney; D Ramsey; D Munoz; R Del Maestro
Journal:  Can J Neurol Sci       Date:  1996-11       Impact factor: 2.104

7.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Authors:  Joanne M Hilden; Sharon Meerbaum; Peter Burger; Jonathan Finlay; Anna Janss; Bernd W Scheithauer; Andrew W Walter; Lucy B Rorke; Jaclyn A Biegel
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

8.  Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

Authors:  Alexander R Judkins; Joanne Mauger; As Ht; Lucy B Rorke; Jaclyn A Biegel
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

9.  Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

Authors:  Roger J Packer; Jaclyn A Biegel; Susan Blaney; Jonathan Finlay; J Russell Geyer; Richard Heideman; Joanne Hilden; Anna J Janss; Larry Kun; Gilbert Vezina; Lucy B Rorke; Malcolm Smith
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

10.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity.

Authors:  L B Rorke; R J Packer; J A Biegel
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

View more
  23 in total

1.  Novel cell lines established from pediatric brain tumors.

Authors:  Jingying Xu; Anat Erdreich-Epstein; Ignacio Gonzalez-Gomez; Elizabeth Y Melendez; Goar Smbatyan; Rex A Moats; Michael Rosol; Jaclyn A Biegel; C Patrick Reynolds
Journal:  J Neurooncol       Date:  2011-11-27       Impact factor: 4.130

Review 2.  Molecular genetics of pediatric central nervous system tumors.

Authors:  Nicole J Ullrich; Scott L Pomeroy
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

3.  Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.

Authors:  Sujatha Venkataraman; Irina Alimova; Tiffany Tello; Peter S Harris; Jeffrey A Knipstein; Andrew M Donson; Nicholas K Foreman; Arthur K Liu; Rajeev Vibhakar
Journal:  J Neurooncol       Date:  2012-01-15       Impact factor: 4.130

4.  CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system.

Authors:  Monika Warmuth-Metz; Brigitte Bison; Elke Dannemann-Stern; Rolf Kortmann; Stefan Rutkowski; Torsten Pietsch
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

5.  Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases.

Authors:  Yeşim Ertan; Murat Sezak; Tuncer Turhan; Mehmet Kantar; Yusuf Erşahin; Saffet Mutluer; Canan Vergin; Haldun Oniz; Taner Akalin
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

6.  Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.

Authors:  Velasco Cimica; Melissa E Smith; Zhikai Zhang; Deepti Mathur; Sridhar Mani; Ganjam V Kalpana
Journal:  BMC Cancer       Date:  2010-11-19       Impact factor: 4.430

7.  Peritoneal metastasis of third ventricular atypical teratoid/rhabdoid tumor after VP shunt implantation for unexplained hydrocephalus.

Authors:  Yi-Peng Han; Yang Zhao; Xiao-Guang He; Jie Ma
Journal:  World J Pediatr       Date:  2012-11-15       Impact factor: 2.764

Review 8.  Primary atypical teratoid/rhabdoid tumor of central nervous system in children: a clinicopathological analysis and review of literature in China.

Authors:  Min Yang; Xi Chen; Ning Wang; Kun Zhu; Ying-Zi Hu; Yun Zhao; Yan Shu; Man-Li Zhao; Wei-Zhong Gu; Hong-Feng Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.

Authors:  Paola Fidani; Maria Antonietta De Ioris; Annalisa Serra; Luigi De Sio; Ilaria Ilari; Raffaele Cozza; Renata Boldrini; Giuseppe Maria Milano; Maria Luisa Garrè; Alberto Donfrancesco
Journal:  J Neurooncol       Date:  2008-11-29       Impact factor: 4.130

10.  Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.

Authors:  Anjali Singh; Xueqing Lun; Aarthi Jayanthan; Halah Obaid; Yibing Ruan; Douglas Strother; Susan N Chi; Amy Smith; Peter Forsyth; Aru Narendran
Journal:  Mol Oncol       Date:  2013-01-11       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.